![]() This acquisition will allow IL to establish a market-leading position in hospital-based POC Hemostasis testing, expand its position in POC Critical Care testing, and complement its leadership of the Hemostasis laboratory segment. ![]() ![]() Werfen and its subsidiary Instrumentation Laboratory (IL) today announced the acquisition of Accriva Diagnostics, a global leader in in vitro diagnostic (IVD) blood testing at the Point-of-Care (POC), including its flagship product portfolio spanning coagulation, platelet aggregation, CO-Oximetry and incision devices. ![]()
0 Comments
Leave a Reply. |